Discover the power of GLP-1 drugs in transforming your health.
Being overweight is a complex condition that often requires multiple therapies, including dietary changes, exercise, medications, and behavior modification programs
Overweight is defined by a BMI of 25 to 29.9, while obesity is categorized by a BMI of 30 or higher
Semaglutide and tirzepatide may be prescribed by healthcare providers for overweight individuals after thorough consultation
Individuals with obesity or overweight who are eligible for GLP-1 injectables can self-administer them once a week for weight loss
Weight loss success varies depending on individual factors, but most clients typically lose around 5% of their initial bodyweight. Some clients may even experience weight loss of up to 10% over a 12-week period. For a 300-pound person, this could mean shedding around 20 to 30 pounds.
Once goal weight is reached, a maintenance dose will be considered or alternative oral medications
The average monthly cost of acquiring Semaglutide and Tirzepatide (a compounded GLP-1) injectable ranges from $250 to $500, depending on the dosage and specific medication, with Tirzepatide being more costly than Semaglutide.